The Pfizer/BioNTech coronavirus vaccine has been approved for use in children aged 12 to 15 years old.

The Medicines and Healthcare products Regulatory Agency (MHRA) authorised the use of the jab in the younger age group on Friday June 4 following a review of its safety, quality and effectiveness.

MHRA chief executive Dr June Raine said the vaccine is “safe and effective” in this age group and that “the benefits of this vaccine outweigh any risk”.

“We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved Covid-19 vaccines and this surveillance will include the 12- to 15-year age group,” she said.

“No extension to an authorisation would be approved unless the expected standards of safety, quality and effectiveness have been met.”